- Amended Current report filing (8-K/A)
21 5월 2010 - 3:25AM
Edgar (US Regulatory)
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
(Amendment
No. 1)
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): May 17, 2010
TIENS
BIOTECH GROUP (USA), INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32477
|
|
75-2926439
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
|
|
Identification
Number)
|
No. 6,
Yuanquan Road, Wuqing
New-Tech Industrial Park, Tianjin,
China
301700
(Address
of principal executive offices)
Registrant's
telephone number, including area code:
(86)
22
-
8213-7335
Not
applicable
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Explanatory Note
This Amendment No. 1 to the
registrant’s Form 8-K, filed with the Securities and Exchange Commission on May
17, 2010, replaces exhibit 99.1 to the 8-K. No other changes are made
to the registrant’s Form 8-K.
Item
2.02 Results of Operations and Financial Condition.
On May
17, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) issued a press release
reporting the Company’s financial results for the fiscal quarter ended March 31,
2010. The full text of the press release is set forth in Exhibit 99.1
attached hereto.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
.
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
release, dated May 17, 2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TIENS BIOTECH
GROUP (USA), INC.
|
|
|
|
|
|
Date: May
19, 2010
|
By:
|
/s/ Manbo
He
|
|
|
|
Name: Manbo
He
|
|
|
|
Title: Chief
Financial Officer
|
|
|
|
|
|
Exhibits
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
release, dated May 17, 2010.
|
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tiens Biotech GR Usa (AMEX:TBV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024